Figure 1.

Overview of molecular targets found in gliomas, glioneuronal tumors, and neuronal tumors of adults and associated ESCAT score.

Notes: - Numbers are rough estimates based on literature and public databases, data on rare or new subtypes for which only a few samples have been characterized may evolve. Whenever feasible, results have been translated into tumor types as they are defined according to the WHO 2021 central nervous system tumor classification. This may be responsible for variations in biomarker prevalence compared to past studies. Definitions of variants may vary between different studies (eg, rare mutations outside known hotspots of which the somatic status is unknown and oncogenic potential has not been determined). Single cases or discordant reports are not included in the table.